US equities
|
NVDA
$237.59
▲+1.55%
MU
$1,059.04
▼-1.48%
SPCX
$164.09
▲+3.22%
MSFT
$528.00
▲+2.02%
TSLA
$374.23
▲+0.98%
INTC
$116.52
▼-2.35%
SNDK
$1,725.94
▲+0.35%
AMD
$630.88
▼-0.48%
NVDA
$237.59
▲+1.55%
MU
$1,059.04
▼-1.48%
SPCX
$164.09
▲+3.22%
MSFT
$528.00
▲+2.02%
TSLA
$374.23
▲+0.98%
INTC
$116.52
▼-2.35%
SNDK
$1,725.94
▲+0.35%
AMD
$630.88
▼-0.48%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Attention Deficit Hyperactive Disorder
Recent news which mentions Attention Deficit Hyperactive Disorder
ADHD Drug Developer Cingulate Plans NASDAQ Debut
September 10, 2021
Tickers
FRX
IPO
IPOS
JNJ
Tags
Briefs
Attention Deficit Hyperactive Disorder
Benzinga
From
Benzinga